In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Luminex, BD, and Prodesse all immediately complied with FDA's instructions in removing statements from their websites related to tests for the 2009 H1N1 flu virus.
Luminex will pay $4.35 million to settle a dispute filed by SUNY in December 2007, which alleged breach of contract.
Shares of Affymetrix and Nanosphere both rose more than 50 percent in March, as the GWDN Index gained 10 percent for the month.
The molecular diagnostics developer's full-year sales swelled 16 percent, as it plans to file for regulatory clearance for a variety of tests.
For full-year 2008, Luminex reported a 39 percent increase in revenues, to $104.4 million from $75 million. The company anticipates 2009 revenues to grow between 25 percent and 34 percent.
A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.
A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.
Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.
In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.